Updated: Wed, 10/09/2024 - 15:16

Oct. 10-11, campus is open to McGill students, employees and essential visitors. Most classes are in-person. See Campus Public Safety website for details.


Les 10 et 11 octobre, le campus est accessible aux étudiants et au personnel de l’Université, ainsi qu’aux visiteurs essentiels. La plupart des cours ont lieu en présentiel. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

Recent Invited Presentations

2010 – Present

June 2023 University of Haifa, Israel The Immuno-tolerant Microenvironment of Liver metastases: Challenges and Opportunities - Invited lecture
June 2023 Liver Metastasis Research Network- Brussels, Belgium The need for a multidisciplinary approach of liver metastasis
March 2023

IGF and Insulin System in Physiology and Disease - Gordon Research Conference- Ventura, California, USA

Targeting the IGF Axis in Pediatric and Adult Glioma - Invited lecture
June 2022 Liver Metastasis Research Network- Sheffield UK The microenvironment of liver metastases: biology and clinical implications- Session Chair and Introductory lecture

June 2022

Pancreatic Cancer UK Discovery and Translational Research Forum, University of Oxford, Oxford, UK The immune-tolerant micro-environment of liver metastases - challenges and opportunities

May 2021

Liver Metastasis Research Network – Virtual Meeting, Montreal, Canada Combinatorial immunotherapy for PDAC liver metastases - insights from animal models.
March 2021 The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute, Columbus, Ohio - Virtual meeting Invitation to speak at Grand Rounds Series for the 2019-20 season.
Visit rescheduled due to travel restrictions
December 2020 Liver Metastasis Research Network – Virtual Meeting, Montreal, Canada The microenvironment of liver metastases – an overview.
November 2018 Presentations to Pfizer Presentation 1: Novel target and potential biomarker for pancreatic ductal adenocarcinoma therapy.
Presentation 2: Targeting invadopodia for blockade of cancer cell invasion and metastasis: role of chemokine signaling.
June 2018 AACR conference on Cancer Dormancy and Residual Disease, Montreal, Canada Glioma cells with downregulated IGF-IR expression can persist in the brain in a dormant state
June 2018 Liver Metastasis Research Network – Annual Meeting, Montreal, Canada Targeting the immune microenvironment of PDAC metastases
December 2017 Annual Research day of the Centre for Excellence in Translation Immunology, Montreal, Canada Sex disparity in the regulation of the immunosuppressive microenvironment of liver metastases
June 2017 Liver Metastasis Research Network – Annual Meeting, Rotterdam, Netherlands Collagen IV-conveyed signals regulate an EMT program and promote expansion of liver-metastases
November 2016 The 8th International Congress of the GRS and IGF Society An IGF-Trap inhibits spontaneous liver metastasis of pancreatic ductal adenocarcinoma
June 2016 Liver Metastasis Research Network – 2016 Annual Meeting, Umea, Sweden Lecture title 1: Type IV collagen conveyed signals can alter chemokine expression and tumour cell interactions with the liver microenvironment.
Lecture title 2: Inhibition of liver metastases from colon and pancreatic cancers by the IGF-Trap - an update.
April 2016 Oncology Lecture, Saint Mary’s Hospital, Montreal, Canada Role of the microenvironment in liver metastasis: from pre- to pro-metastatic niches
March 2016 The McGill Students' Chapter of the Canadian Liver Foundation Role of the microenvironment in liver metastasis
June 2015 Liver Metastasis Research Network – 2015 Annual Meeting, Madrid, Spain The role of the IGF axis in liver metastasis
June 2015 EACR-AACR-SIC 2015 Special Conference, Florence, Italy Regulation of the immunosuppressive microenvironment of liver metastases by TNFR2
July 2014 University of California, San Diego Origin, regulation and function of hepatic stellate cells in colorectal cancer liver metastasis
November 2013 Colorectal Cancer Association of Canada - Montreal, Canada Personalised medicine in the management of colorectal cancer. (Session Chair)
June 2013 International meeting of the Liver Metastasis Research Network - Montreal, Canada Role of the microenvironment in liver metastasis.
October 2012 The 40th annual meeting of the International Society of Oncology and Biomarkers - Jerusalem, Israel An IGF-Trap for the treatment of Cancer.
March 2012 Conference on the Biology of Liver Metastasis - Copenhagen, Denmark Role of the microenvironment in liver metastasis.
November 2011 The 5th China Medicinal Biotech Forum – Beijing, China Developing an IGF-I receptor decoy as an anti-cancer drug. – Keynote speaker
June 2011 Montreal International Symposium on Angiogenesis and Metastasis (MISAM) The molecular landscape of liver-specific metastasis – What have we learnt.
May 2011 Crossroad for BioTransfer 2011 - NRC Biotechnology Research Institute Soluble IGF-I receptor for treatment of cancer and metastasis
February 2011 Gordon Research conference on Insulin-like Growth factors in Physiology and Disease - Ventura, Ca. USA Multipronged regulation of the tumor microenvironment by the IGF axis.
August 2010 15th International Symposium of the International Society of Cells of the Hepatic Sinusoids Distinct and gender-specific roles of the TNF receptors in liver metastasis.
July 2010 Quebec-Israel Joint Colloquium on Drug Discovery and Development - Jerusalem, Israel Developing an IGF Trap for cancer therapy: Progress and Challenges.
May 2010 5th Canadian Gene therapy and Vaccine Symposium - Lac Carling, Canada Use of an IGF-Trap for Cancer Therapy.

 

Back to top